News ReleasesRSS
- May 10, 2021 Chugai Reached Agreement with Japanese Government regarding Investigational Antibody Cocktail (casirivimab and imdevimab) for COVID-19
- May 10, 2021 Chugai Discontinues Marketing of Photodynamic Diagnostic Agent "ALAGLIO® Divided Granules 1.5g"
- May 06, 2021 Research Collaboration by Chugai, the University of Tokyo and RIKEN on Functional Genome Database Published in Cell
- Apr 26, 2021 CHMP Recommends EU Approval of Chugai’s Enspryng (Satralizumab) for Neuromyelitis Optica Spectrum Disorder (NMOSD)
- Apr 22, 2021 Chugai Announces 2021 1st Quarter Results
What's NewRSS
- May 14, 2021 Events & Presentations has been updated with the Date of Chugai Information Meeting on Polivy
- Apr 23, 2021 Webcast of 1Q Results (Jan-Mar 2021) Conference Call
- Apr 22, 2021 1Q Results (Jan-Mar 2021) Conference Call
- Apr 22, 2021 Financial Results for First Quarter of Fiscal Year 2021 (Jan-Mar 2021)
- Apr 01, 2021 Corporate Governance Report
Share price
Pick Up
For more information
Aiming to be a company where everyone can shine
Feature: Chugai’s Sustainability Activities
Recent Social Contribution Activities
-
Wheelchair Softball Trail Session
-
Contribution to Global Environmental Protection - Efforts to protect water resources through forest maintenance at our production site -
-
Workshop on Multidisciplinary Team Care in Cambodia
